← Back to Peptide Library

Adamax

Community reports
Cognitive & brain

A supposedly improved version of Semax — but the molecule has never been tested, and its record is completely empty.

What it is

Adamax is a nootropic peptide sold for focus and memory. It is built by taking Semax, a known Russian peptide, and bolting two chemical caps onto it: one to slow its breakdown and one to help it cross into the brain. The chemistry is exact, but no paper anywhere describes making or testing the finished molecule.

How it works

The mechanism is borrowed from its two parents. Semax acts in the brain and the acetyl cap is meant to stop enzymes from degrading it. The other cap, an adamantane group, is meant to help it cross the blood-brain barrier. Both ideas come from real research — on different molecules — but nobody has looked at what the joined molecule does.

What people report

  • Built from two genuinely researched sets of chemistry
  • The design logic (a longer-lasting Semax) is internally consistent
  • Circulating marketing copy describes it as a better Semax
  • Even its existence as a product is a widely repeated, unsourced claim

Typical use

None exists. No one has ever studied Adamax in any species.

Dosing reference

There is no reference dose. Any human numbers found in marketing copy were measured on Semax, a different molecule. Verify nothing — there is nothing to verify.

Reference only — not a recommendation. Verify via primary sources.

Watch for

Every registry returns zero results for this compound, and no origin paper, patent, or named developer exists. The strongest related evidence actually points against the borrowed mechanism. Treat any claim about it as unsupported.

Educational content — not medical advice.